I got a well-meaning email from a well-known Sloper who was intrigued at my creation of SlopeCharts. Since web-based charting has been around for many years, and quite a few companies (with lots of money and lots of employees) have already done it……..why bother doing it again? Why re-invent the wheel?
My initial motivation, as I’ve explained in earlier posts, was to give myself a charting platform that I liked. I never intended to re-create charting. As the saying goes, “been there, done that”, and it’s a lot of work. However, I tried – – I really, really tried – – to find something out there that I liked, and I hated all the offerings. Some were better than others, but I didn’t really like any of them. So I set about on my task. (more…)
By Mike Golembesky, ElliottWaveTrader.net
In early September I wrote an article that asked the question, “Is it back to buy the dip or time to sell the rip?”
Since the publication of that article, the Dow has moved up over 900 points off of the low that was struck on September 5th. So clearly the answer to the question asked early this month was that it was still indeed time to buy the dip on the Dow Jones Industrial Average.
We now ask how much higher can the Dow go prior to seeing a significant retracement as we enter the final quarter of 2017? (more…)
Note from Tim: I got a nice email from a Sloper who thought the blog could use some trades more at the beginner level; he kindly included two of his own to get things started. Here is the first…….
This is the first post of hopefully many more. The concept is to post a trading idea that starts a discussion about the trade. The post is for novices like me to learn from each other especially from the experienced Slopers. I have laid out the basics of the company, the trade idea and then the charts. As you can see, the charts are very basic and hopefully will become more sophisticated as experience and feedback occurs. Please join in the trading discussion:
- Kemet Corp (KEM) – Manufacturers capacitors for electronic OEMS. EPS is projected to increase 292% for 2017 and 4.4& in 2018.
- IBD has a very high composite rating of 99 (out of 100) and ranks their industry group very high
- Zacks rating is a 3 (1 – 5 rating, 1 strong buy, 5 strong sell), and average analyst rating of bullish (9 analyst).
- Stock has fair liquidity, earnings release 11/7